{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:19:00Z","timestamp":1792549140233,"version":"4.5.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["235777276\/GRK1976"],"award-info":[{"award-number":["235777276\/GRK1976"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC992"],"award-info":[{"award-number":["CRC992"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Ju295\/14-1"],"award-info":[{"award-number":["Ju295\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Si868\/15-1"],"award-info":[{"award-number":["Si868\/15-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["MINECO SAF2017-88975R (A.V.)"],"award-info":[{"award-number":["MINECO SAF2017-88975R (A.V.)"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2017-SGR148 (A.V.)"],"award-info":[{"award-number":["2017-SGR148 (A.V.)"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00657","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:32:36Z","timestamp":1588221156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Sirtuin 1 Inhibiting Thiocyanates (S1th)\u2014A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases"],"prefix":"10.3389","volume":"10","author":[{"given":"Nathalie","family":"W\u00f6ssner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayan","family":"Alhalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Swyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schmidtkunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib","family":"Ovaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Einsle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/med.21436","article-title":"The current state of NAD+ -dependent histone deacetylases (sirtuins) as novel therapeutic targets","volume":"38","author":"Schiedel","year":"2018","journal-title":"Med Res Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-016-0224-3","article-title":"Sirtuin functions and modulation: from chemistry to the clinic","volume":"8","author":"Carafa","year":"2016","journal-title":"Clin Epigenetics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/tcr.201800044","article-title":"Opening the selectivity pocket in the human lysine deacetylase Sirtuin2 - new opportunities, new questions","volume":"18","author":"Robaa","year":"2018","journal-title":"Chem Rec"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.ddtec.2012.08.003","article-title":"The controversial world of sirtuins","volume":"12","author":"Dang","year":"2014","journal-title":"Drug Discov Today Technol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","article-title":"Sirtuin activators and inhibitors: promises, achievements, and challenges","volume":"188","author":"Dai","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5483\/BMBRep.2019.52.1.290","article-title":"Sirtuin signaling in cellular senescence and aging","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep"},{"key":"B8","first-page":"15","article-title":"SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis","volume":"1","author":"Park","year":"2012","journal-title":"Transl Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1101\/gad.211342.112","article-title":"The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation","volume":"27","author":"Serrano","year":"2013","journal-title":"Genes Dev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccell.2016.02.007","article-title":"A SIRT2-selective inhibitor promotes c-Myc oncoprotein degradation and exhibits broad anticancer activity","volume":"29","author":"Jing","year":"2016","journal-title":"Cancer Cell."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1021\/acs.jmedchem.5b01517","article-title":"Aminothiazoles as potent and selective Sirt2 inhibitors: a structure-activity relationship study","volume":"59","author":"Schiedel","year":"2016","journal-title":"J Med Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1248\/bpb.b16-00520","article-title":"Identification of a selective sIRT2 inhibitor and its anti-breast cancer activity","volume":"39","author":"Shah","year":"2016","journal-title":"Biol Pharm Bull"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1021\/acs.jmedchem.6b01609","article-title":"Development of 1,2,4-oxadiazoles as potent and selective inhibitors of the human deacetylase Sirtuin 2: structure-activity relationship, X-ray crystal structure, and anticancer activity","volume":"60","author":"Moniot","year":"2017","journal-title":"J Med Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-018-4710-1","article-title":"Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines","volume":"18","author":"Kozako","year":"2018","journal-title":"BMC Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/cmdc.201800391","article-title":"Direct comparison of SIRT2 inhibitors: potency, specificity, activity-dependent inhibition, and on-target anticancer activities","volume":"13","author":"Spiegelman","year":"2018","journal-title":"ChemMedChem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3324\/haematol.2017.182675","article-title":"The role of SIRT6 in tumors","volume":"103","author":"Desantis","year":"2018","journal-title":"Haematologica."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41589-018-0150-0","article-title":"Identification of a cellularly active SIRT6 allosteric activator","volume":"14","author":"Huang","year":"2018","journal-title":"Nat Chem Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-15-1638","article-title":"SIRT6 overexpression potentiates apoptosis evasion in hepatocellular carcinoma via BCL2-associated X protein-dependent apoptotic pathway","volume":"22","author":"Ran","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3324\/haematol.2017.176248","article-title":"Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents","volume":"103","author":"Cagnetta","year":"2018","journal-title":"Haematologica."},{"key":"B20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bcp.12512","article-title":"An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease","volume":"79","author":"S\u00fcssmuth","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1002\/jcp.26302","article-title":"Narrower insight to SIRT1 role in cancer: a potential therapeutic target to control epithelial-mesenchymal transition in cancer cells","volume":"233","author":"Choupani","year":"2018","journal-title":"J Cell Physiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11010-019-03559-y","article-title":"Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial-mesenchymal transition in ovarian carcinoma","volume":"459","author":"Yang","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajpath.2014.09.014","article-title":"Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria","volume":"185","author":"Di Sante","year":"2015","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","article-title":"Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence","volume":"74","author":"Long","year":"2014","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"Vaziri","year":"2001","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ncb1468","article-title":"Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage","volume":"8","author":"Wang","year":"2006","journal-title":"Nat Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gendis.2017.11.001","article-title":"Effect of Sirtuin 1 inhibition on matrix metalloproteinase 2 and Forkhead box O3a expression in breast cancer cells","volume":"4","author":"Abdelmawgoud","year":"2017","journal-title":"Genes Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cancers10110409","article-title":"Breaking down the contradictory roles of histone deacetylase SIRT1 in human breast cancer","volume":"10","author":"Rifa\u00ef","year":"2018","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.7150\/jca.24275","article-title":"SIRT1 promotes formation of breast cancer through modulating Akt activity","volume":"9","author":"Jin","year":"2018","journal-title":"J Cancer."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/emm.2007.2","article-title":"SIRT1 promotes DNA repair activity and deacetylation of Ku70","volume":"39","author":"Jeong","year":"2007","journal-title":"Exp Mol Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2008.10.025","article-title":"SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging","volume":"135","author":"Oberdoerffer","year":"2008","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-\u03baB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajpath.2014.10.002","article-title":"The role of SIRT1 in cancer: the saga continues","volume":"185","author":"Wilking","year":"2015","journal-title":"Am J Pathol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"66343","DOI":"10.18632\/oncotarget.18494","article-title":"The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"B36","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/1535-7163.MCT-09-0971","article-title":"SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2","volume":"9","author":"Peck","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1007\/s13277-015-3300-y","article-title":"Expression\/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells","volume":"36","author":"Singh","year":"2015","journal-title":"Tumor Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.4161\/15384101.2014.949085","article-title":"Sirtuin deacetylases: a new target for melanoma management","volume":"13","author":"Wilking","year":"2014","journal-title":"Cell Cycle."},{"key":"B39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/15384047.2016.1139246","article-title":"Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-cell chronic lymphocytic leukemia (CLL)","volume":"17","author":"Bhalla","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.toxlet.2018.03.011","article-title":"Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines","volume":"289","author":"Ceballos","year":"2018","journal-title":"Toxicol Lett"},{"key":"B41","first-page":"305","article-title":"\u03b3-H2AX - a novel biomarker for DNA double-strand breaks","volume":"22","author":"Kuo","year":"2008","journal-title":"In Vivo"},{"key":"B42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ccr.2008.09.001","article-title":"Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice","volume":"14","author":"Wang","year":"2008","journal-title":"Cancer Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/BJ20130670","article-title":"Histone deacetylase SIRT1 modulates and deacetylates DNA base excision repair enzyme thymine DNA glycosylase","volume":"456","author":"Madabushi","year":"2013","journal-title":"Biochem J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.stemcr.2017.06.001","article-title":"SIRT1 enhances the survival of human embryonic stem cells by promoting DNA repair","volume":"9","author":"Jang","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"19025","DOI":"10.1074\/jbc.RA118.003940","article-title":"Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage","volume":"293","author":"Jarrett","year":"2018","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1159\/000493815","article-title":"KU70 Inhibition impairs both non-homologous end joining and homologous recombination DNA damage repair through SHP-1 induced dephosphorylation of SIRT1 in adult T-cell leukemia-lymphoma cells","volume":"49","author":"Yu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3390\/ijms20133153","article-title":"The role of SIRT1 on DNA damage response and epigenetic alterations in cancer","volume":"20","author":"Alves-Fernandes","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/labinvest.2015.119","article-title":"Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target","volume":"95","author":"Asaka","year":"2015","journal-title":"Lab Investig"},{"key":"B49","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.1021\/jm050522v","article-title":"Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1","volume":"48","author":"Napper","year":"2005","journal-title":"J Med Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/cmdc.200700003","article-title":"Structure-activity studies on suramin analogues as inhibitors of NAD + -dependent histone deacetylases (sirtuins)","volume":"2","author":"Trapp","year":"2007","journal-title":"ChemMedChem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4155\/fmc-2017-0207","article-title":"Recent advances in inhibitors of sirtuin1\/2: an update and perspective","volume":"10","author":"Zhou","year":"2018","journal-title":"Future Med Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"0210","DOI":"10.1371\/journal.pbio.0030041","article-title":"SIRT1 regulates HIV transcription via tat deacetylation","volume":"3","author":"Pagans","year":"2005","journal-title":"PLoS Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.bmcl.2017.01.088","article-title":"Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3\u2032-indoline]-2\u2032,4(3H)-diones and their evaluation for anticancer activity","volume":"27","author":"Ismail Kuthati","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"B54","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1021\/acs.jmedchem.6b01872","article-title":"Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals)","volume":"61","author":"Schiedel","year":"2018","journal-title":"J Med Chem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature."},{"key":"B56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ymeth.2005.03.003","article-title":"In vitro assays for the determination of histone deacetylase activity","volume":"36","author":"Heltweg","year":"2005","journal-title":"Methods."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1021\/ml3002709","article-title":"Inhibitors of the NAD+-dependent protein desuccinylase and demalonylase sirt5","volume":"3","author":"Maurer","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"B59","doi-asserted-by":"publisher","first-page":"20170083","DOI":"10.1098\/rstb.2017.0083","article-title":"New chemical tools for probing activity and inhibition of the NAD+ -dependent lysine deacylase sirtuin 2","volume":"373","author":"Swyter","year":"2018","journal-title":"Philos Trans R Soc"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat Protoc"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1021\/ja309802n","article-title":"On terminal alkynes that can react with active-site cysteine nucleophiles in proteases","volume":"135","author":"Ekkebus","year":"2013","journal-title":"J Am Chem Soc"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1038\/ncomms7263","article-title":"Selective Sirt2 inhibition by ligand-induced rearrangement of the active site","volume":"6","author":"Rumpf","year":"2015","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei","volume":"11","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/jm301431y","article-title":"The 2.5 \u00c5 crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition","volume":"56","author":"Zhao","year":"2013","journal-title":"J Med Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J Comput Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking11 edited by F","volume":"267","author":"Jones","year":"1997","journal-title":"E Cohen J Mol Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3945\/jn.109.113332","article-title":"Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention","volume":"139","author":"Ho","year":"2009","journal-title":"J Nutr"},{"key":"B69","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbamcr.2004.10.003","article-title":"Mechanism and function of deubiquitinating enzymes","volume":"1695","author":"Amerik","year":"2004","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","article-title":"Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes","volume":"18","author":"Altun","year":"2011","journal-title":"Chem Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.bbamcr.2012.04.011","article-title":"The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases","volume":"1823","author":"Seiberlich","year":"2012","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2008.01.019","article-title":"The Sirtuin family: therapeutic targets to treat diseases of aging","volume":"12","author":"Milne","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0959-440X(03)00003-4","article-title":"Applications of calorimetric methods to drug discovery and the study of protein interactions","volume":"13","author":"Weber","year":"2003","journal-title":"Curr Opin Struct Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1529\/biophysj.108.134973","article-title":"A quantitative model of thermal stabilization and destabilization of proteins by ligands","volume":"95","author":"Cimmperman","year":"2008","journal-title":"Biophys J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1517\/17460441.2013.806479","article-title":"Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization","volume":"8","author":"Simeonov","year":"2013","journal-title":"Expert Opin Drug Discov"},{"key":"B76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1517\/17460441.2012.666235","article-title":"Thermodynamic studies for drug design and screening","volume":"7","author":"Garbett","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1039\/C5MB00205B","article-title":"Selectivity hot-spots of sirtuin catalytic cores","volume":"11","author":"Parenti","year":"2015","journal-title":"Mol Biosyst"},{"key":"B78","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jnci\/85.4.271","article-title":"The current status of camptothecin analogues as antitumor agents","volume":"85","author":"Slichenmyer","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"B79","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.toxlet.2014.07.002","article-title":"Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols","volume":"229","author":"Ryckewaert","year":"2014","journal-title":"Toxicol Lett"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/ajoc.201800668","article-title":"Rational design and synthesis of reversible covalent PPAR\u03b3 antagonistic ligands inhibiting Ser273 phosphorylation","volume":"8","author":"Kim","year":"2019","journal-title":"Asian J Org Chem"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:32:43Z","timestamp":1588221163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":80,"alternative-id":["10.3389\/fonc.2020.00657"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00657","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"657"}}